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Abstract
One of the main Mycoplasma hyopneumoniae (M. hyopneumoniae) swine experimental
model objectives is to reproduce mycoplasmal pneumonia (MP). Unfortunately, experimental
validated protocols to maximize the chance to successfully achieve lung lesions induced by M.
hyopneumoniae are not available at the moment. Thus, the objective of this work was to iden-
tify those factors that might have a major influence on the effective development of MP, mea-
sured as macroscopic lung lesions, under experimental conditions. Data from 85 studies
describing M. hyopneumoniae inoculation experiments were compiled by means of a system-
atic review and analyzed thereafter. Several variables were considered in the analyses such
as the number of pigs in the experiment, serological status against M. hyopneumoniae, source
of the animals, age at inoculation, type of inoculum, strain of M. hyopneumoniae, route, dose
and times of inoculation, study duration and co-infection with other swine pathogens. Descrip-
tive statistics were used to depict M. hyopneumoniae experimental model main characteristics
whereas a recursive partitioning approach, using regression trees, assessed the importance
of the abovementioned experimental variables as MP triggering factors. A strong link between
the time period between challenge and necropsies and lung lesion severity was observed.
Results indicated that the most important factors to explain the observed lung lesion score var-
iability were: (1) study duration, (2) M. hyopneumoniae strain, (3) age at inoculation, (4) co-
infection with other swine pathogens and (5) animal source. All other studied variables were
not relevant to explain the variability on M. hyopneumoniae lung lesions. The results provided
in the present work may serve as a basis for debate in the search for a universally accepted M.
hyopneumoniae challenge model.
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Introduction
Mycoplasma hyopneumoniae (M. hyopneumoniae) has been recognized as the etiological agent
of enzootic pneumonia (EP) and a relevant infectious agent of the porcine respiratory disease
complex (PRDC). Both are chronic respiratory diseases affecting mainly grow-finishing pigs,
causing major economic losses in the pig industry worldwide[1]. Mycoplasmal pneumonia
(MP) is grossly characterized by purple to grey areas of pulmonary consolidation, mainly
found bilaterally in the apical, cardiac, intermediate and the anterior parts of the diaphrag-
matic lobes [2]. Such lung lesions can be experimentally induced in pigs inoculated with M.
hyopneumoniae [3].
M. hyopneumoniae experimental swine models have been primarily used to study the path-
ogenesis of the infection as well as to evaluate the efficacy of antibiotics or vaccines [3]. How-
ever, variation in the outcome of such experimental models (in terms of number of animals
affected by MP and its severity) is a common drawback. In fact, in this scenario, clinical course
and pattern of M. hyopneumoniae infection have been described to be dependent on several
factors such as co-infection with other pathogens [4–6], study duration [7, 8], differences in
virulence between M. hyopneumoniae strains [9, 10], inoculum type [11], dose [12] or inocula-
tion route [13]. The abovementioned factors together with other conditions highly differ
between published experiments, becoming difficult to elucidate specific conclusions regarding
their influence on MP development and severity. As a result, a reference-validated model for
the experimental MP reproduction in swine is still unavailable. In consequence, the present
study sought to identify determinants for the successful reproduction of MP under experimen-
tal settings. To reach this goal, a systematic review approach was used for the comprehensive
assessment of M. hyopneumoniae experimental model characteristics as well as for identifica-
tion of relevant studies. Subsequently, recursive partitioning was applied to the compiled data
to evaluate the influence of experimental conditions on lung lesion outcomes.
Materials and methods
Data source and literature review
The protocol for the current systematic review is in accordance with the Preferred Reporting
Items of Systematic Reviews and Meta-analysis (PRISMA) guidelines (see S1 PRISMA Check-
list) [22]. The search term “Mycoplasma hyopneumoniae” was used in Medline1/PubMed1
database (https://www.ncbi.nlm.nih.gov/pubmed) for peer-reviewed articles describing M.
hyopneumoniae swine experimental models from January 1990 to May 2016. Those relevant
citations contained links to full-text content from PubMed Central (PMC), National Center
for Biotechnology Information (NCBI) Bookshelf and different publisher web sites. Only arti-
cles written in English were considered. In addition, those pertinent studies cited in the refer-
ence list of the abovementioned articles were also systematically reviewed. The term “study”
was used to define a published M. hyopneumoniae experimental inoculation work and “experi-
mental unit” to define a particular set of experimental conditions applied in one or more pigs
within a study. While in some studies a unique set of conditions was applied, others included
more than one experimental unit.
Study inclusion criteria
Eligible studies were those providing: 1) information in regards of MP prevalence and/or mac-
roscopic score (considering also those with no success for MP achievement); and 2) at least
one experimental unit including M. hyopneumoniae-inoculated pigs (with or without co-infec-
tion with other swine pathogens). Therefore, those experimental units in which pigs were
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mock inoculated, immune stimulated (through vaccination or adjuvantation) or contact-
exposed to M. hyopneumoniae were not considered. On the contrary, experimental units
within a study meeting the two abovementioned inclusion criteria were systematically intro-
duced into a database (Excel 2013 software, Microsoft Office1).
Data extraction and adequacy
Several variables were annotated from each experimental unit accomplishing the aforesaid
inclusion criteria (Table 1). For the inoculation route (InRoute) variable, the term intratracheal
(IT) referred to those methods placing the inoculum directly into the trachea, including both
endotracheal and transtracheal systems. In regards to M. hyopneumoniae strain (Strain) vari-
able, the term “pool” was applied in those experimental units in which more than one strain
were used simultaneously or subsequently to inoculate the animals. In addition, for the addi-
tional challenge with other swine pathogens (CoIn), it was considered either when M. hyop-
neumoniae was co-inoculated before, at the same time or after another bacterial or viral
microorganism. Lastly, a major setback of the systematic review process was the fact that dif-
ferent lung lesion scoring systems were used along the different compiled studies. In conse-
quence, recently reported formulae of equivalence were applied to homogenize mean lung
lesion scores between experimental units [14]. Thus, all scores were converted into the
Table 1. Name, description, abbreviation and classification of the variables annotated within experimental units and included in the statistical
analyses. Levels within categorical variables are also indicated.
Variable Description Abbreviation Classification Variable Levels Abbreviation
Sample size Number of pigs included in an experimental unit SamSize Continuous — —
Age at inoculation Weeks of age of the animals when inoculated InAge Continuous — —
Inoculation dose Amount of M. hyopneumoniae (expressed in color
changing units; CCU) given to each animal
Dose Continuous — —
Days of inoculation Number of days in which the inoculum is given InDays Continuous — —
Necropsy Post-inoculation week in which animals were
necropsied and lung lesions evaluated
Nweek Continuous — —
Lung lesion
prevalence
Proportion of affected lungs within an experimental unit Llprop Continuous — —
Lung lesion score Mean lung lesion score (Ph. Eur.) in each experimental
unit expressed as weight percentage of affected tissue
Llscore Continuous — —
Seronegativity Seronegative for M. hyopneumoniae before inoculation SerNeg Categorical Yes —
No —
Source of animals Source and health/immunological status of the animals Asource Categorical Conventional C
Caesarean-derived,
colostrum-deprived
CDCD
Specific-pathogen free SPF
Route of inoculation Route used for the inoculum administration to the
animals
InRoute Categorical Intratracheal IT
Intranasal IN
Aerosol AE
M. hyopneumoniae
strain
M. hyopneumoniae strain used for challenge Strain Categorical — —
Type of inoculum Type of challenge material InType
Categorical
Lung homogenate LH
Culture CT
Lung homogenate and
pure culture mixed
LH+CT
Co-infection Additional challenge with other swine pathogens CoIn Categorical Yes —
No —
https://doi.org/10.1371/journal.pone.0181194.t001
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European Pharmacopoeia score (Ph. Eur., monograph number 04/2013:2448), which expresses
the weight percentage of affected lung tissue by MP.
Data analyses
Univariate statistics. Descriptive statistics were used to analyze variables and summarize
their main characteristics (Excel 2013 software, Microsoft Office1). Distribution, central ten-
dency and dispersion parameters were calculated for continuous variables whereas frequency
distribution bar charts were created for categorical variables.
Multivariate statistics. The contribution of the previously mentioned variables to the
experimental induction of MP was assessed through a recursive partitioning analysis via deci-
sion tree models construction. Thus, tree-based models were grown and pruned by using the
rpart 4.1–10 package [15] in the R software version 3.3.2 [16]. The pruning procedure reduces
the size of the original tree, simplifying and facilitating its interpretation and avoiding overfit-
ting data [17, 18]. In the present work, decision trees were pruned according to a complexity
parameter (CP), defined as the cost (in terms of relative error reduction) of adding another
variable to the model. Hence, models were started with a low CP value (CP = 0.001) and after-
wards, the most parsimonious trees were obtained by using the CP obtained from the model
with the lower prediction error after 10 cross validations. In addition, 12 experimental units
were the minimum number of observations needed to generate a node. Lastly, an overall mea-
sure of variable importance (VIP) and the percentage of the observed MP variability, retained
in the final and most parsimonious regression tree models, were calculated. A generalized
additive model [19], which describes the non-linear relationships via nonparametric smooth-
ing functions, was applied to further investigate associations between variables. This model
was constructed using the R software 3.3.2 version [16] and the mgcv 1.8–12 package [20].
Results
Included studies
Study selection flow diagram is shown in Fig 1. Electronic search in Medline1/PubMed1
database produced an initial list of 643 references until 1990 (last entry in May 2016). An addi-
tional article written in Chinese was identified in other sources [21]. Examination of titles,
abstracts and reference lists in the retrieved articles led to a preliminary list of 142 potentially
relevant studies (M. hyopneumoniae experimental inoculations reported), which, after removal
of duplicities, were reduced to 136. After examination of full text, 85 studies, including a total
of 261 experimental units, complied with the inclusion criteria and therefore, they were
included in the analyses.
Descriptive analysis
Since different variables were specified in each experimental unit, the number of experimental
units considered for the analyses differed between variables. Main descriptive statistics calcu-
lated for continuous variables and the number of experimental units considered for each vari-
able is summarized in Table 2, whereas frequency distribution bar charts for categorical
variables are shown in Fig 2. Only those strains appearing in at least three experimental units
not coming from the same study were considered for analyses. Fig 3 displays the frequency dis-
tribution bar chart of considered M. hyopneumoniae strains together with an alphanumerical
reference and the countries where they were used.
The mean sample size within experimental units was approximately of 8 inoculated pigs.
Nonetheless, experimental units including only one pig were the most prevalent ones. The latter
Mycoplasmal pneumonia experimental determinants
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is probably explained because of the impact of a unique study with numerous experimental
units of 1 pig each [8]. Conventional pigs were used in more than the half of the experimental
units and free-M. hyopneumoniae antibody animals were principally chosen. In regards of the
Fig 1. Flowchart depicting the flow of information (records identified, included and excluded) through the different phases of the systematic
revision. PRISMA guidelines were followed [22].
https://doi.org/10.1371/journal.pone.0181194.g001
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inoculation procedure, pigs were often challenged at 6 weeks of age through the IT inoculation
route in one time. Concerning the inoculum, M. hyopneumoniae broth culture (CT) was applied
in the majority of cases. The dosage given per pig was greatly variable, reaching a maximum of
Table 2. Descriptive statistics calculated for continuous variables within each experimental unit and the number of experimental units considered
for each variable.
Distribution Central tendency Dispersion
No. of experimental units Units Range Mean Median Mode Standard deviation
SamSize 261 No. of pigs 1–116 7.66 5 1 10.10
InAge 258 Week 1–17 6.04 6 6 3.61
Dose 234 CCU/pig 2.19–1.50 x 1015 3.21 x 1013 7 x 108 107 2.17 x 1014
InDays 261 Day 1–6 1.56 1 1 0.91
Nweek 252 Week 1–52 6.29 4 4 6.85
Llprop 160 Percentage 0–100 71.96 100 100 39.60
Llscore 227 Percentage 0–51.82 9.83 8.01 0 9.10
https://doi.org/10.1371/journal.pone.0181194.t002
Fig 2. Frequency distribution bar charts of SerNeg (A), ASource (B), InRoute (C), InType (D) and CoIn (E) categorical variables.
https://doi.org/10.1371/journal.pone.0181194.g002
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1.50 x 1015 CCU [23]. Such a large dose displaced the mean to a high value, but the median dose
per animal was 7 x 108 CCU, being 107CCU/pig the most prevalent inoculum dose. Nearly one
quarter of the experimental units used co-infection with other viral and bacterial swine respira-
tory pathogens. In decreasing order of importance, the pathogens co-inoculated were Porcine
reproductive and respiratory syndrome virus, Swine influenza virus, Porcine circovirus type 2 and
bacterial pathogens such as Actinobacillus pleuropneumoniae or Pasteurella multocida. The
mean study duration was found to be about 6 weeks, although in most of the cases the animals
were necropsied after 4 weeks post-inoculation (wpi). As outcomes, the mean percentage of
lungs affected by MP within an experimental unit was 72% and the mean lung lesion score
(Ph. Eur.) was around 10% of lung weight damaged. Importantly, from the 261 included
Fig 3. Frequency distribution bar chart along experimental units of those well-defined M. hyopneumoniae strains, the given alphanumerical
reference and the countries where their use has been reported.
https://doi.org/10.1371/journal.pone.0181194.g003
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experimental units, 30 (11.5%) did not manage to reproduce MP. The use of a given strain was
found to be closely related with the laboratory or research group. M. hyopneumoniae 232 was
the most largely used strain, mainly by the United States research groups. In Europe, a higher
variability is seen, but French M. hyopneumoniae BQ14 and 116 strains were the most prevalent
through experimental units from this continent. Notably, the use of a pool of M. hyopneumoniae
strains, meaning simultaneous or subsequent inoculations of at least two different strains, has
been reported in experimental inoculation models only in Europe. In Asia, the Japanese E-1
strain was found to be the most commonly used one. Lastly, two different strains were handled
in Australia, named Beaufort and Hillcrest.
Multivariate analysis
Since the Llscore variable was more commonly specified within experimental units (n = 227)
than the Llprop one (n = 160), the former was chosen as response variable in the multivariate
analysis (74 studies considered). The explanatory variables were: InAge, Asource, InRoute,
Strain, InType, Dose, InDays, CoIn and Nweek. Giving the fact that only 3 experimental units
from 2 studies used M. hyopneumoniae seropositive pigs [24, 25], SerNeg variable was not con-
sidered in recursive partitioning.
In a first obtained tree-based model, in which all explanatory variables were fitted to get the
full picture of the model, Nweek was the most important variable by far as shown by an ad hoc
ANOVA test (F9, 215 = 6.36, p-value = 5.485e-08, R2 = 21%). Using GAM, the strong connection
between Nweek and Llscore variables was reinforced (F = 10.71, edf = 5.95, p-value = 3.34e-11,
R2 = 30%). Indeed, Llscore peaked when necropsies were performed at 4 wpi, dropping later at
8 wpi (Fig 4). Thus, the first obtained decision tree established that successful protocols were
those assessing MP below 8wpi; specifically, the top ten Llscore were obtained between 3 and 7
wpi. Consequently, and in order to enable the identification of other putative influencing factors
on the Llscore variability, another tree-based model was obtained from the adjustment of data
from experimental units with a maximum duration of 8 wpi. As a result, the final decision tree
explained 33% of the observed Llscore variability (Fig 5) and, in decreasing order of importance,
the factors to be accounted to successfully reproduce MP in experimental units of duration
below8 wpi were the following: Strain (VIP = 67), InAge (VIP = 18), CoIn (VIP = 9) and finally,
Asource (VIP = 5). Overall, M. hyopneumoniae strains 116, 75/2002, Beaufort, BQ14, Hillcrest,
JS and P5722-3 resulted in higher Llscore values than all the other assessed strains. Importantly,
some of the aforesaid strains lead to the highest Llscore in co-infected pigs (Llscore = 24%,
n = 11).Nonetheless, sole inoculation with 75/2002 or JS strains resulted in similar Llscore val-
ues (Llscore = 23%, n = 8) to those reached in co-infection. All the remaining strains resulted
in lower Llscore outcomes, particularly when the age of pigs at inoculation was lower than 3.5
weeks (Llscore = 2.6%, n = 20).When above 3.5 weeks of age, inoculated specific pathogen-free
(SPF) pigs showed higher Llscore values (Llscore = 24%, n = 11) than their C or cesarean-
derived, colostrum-deprived (CDCD) counterparts (Llscore = 8.4%, n = 102).All the other ana-
lyzed variables, namely InRoute, InDays, InType and Dose,werenot found relevant to explain
Llscore.
Discussion
Numerous attempts to induce MP at experimental level have been reported and, as evi-
denced by the present results, variation in both the number of animals affected by MP as
well as in severity of such lung lesions do occur. The latter is accompanied by wide differ-
ences between M. hyopneumoniae experimental models, though highlighting the existing
inconstancy between protocols. Works studying how a unique variable may influence MP
Mycoplasmal pneumonia experimental determinants
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under experimental settings have been already made [7, 8, 10–13]. Contrarily, observation
and analysis of more than one experimental variable at a time has not been assessed. In con-
sequence, a combination of experimental factors that would increase the chance to success-
fully achieve MP is not available and the uncertainty around this problem is still far of being
mitigated. Therefore, the present work investigated which experimental conditions might
be accounted for reproduction of MP, determined by the macroscopic lung lesion score,
and proposes the initial bases to build are producible and effective M. hyopneumoniae chal-
lenge model pursuing this goal.
In order to accomplish the abovementioned objective, data from a series of studies were
summarized through a systematic review and analyzed by means of recursive partitioning. To
authors’ knowledge, this is the first time that such statistical method has been applied to
Fig 4. Plot representing the distribution of values for the Llscore variable depending on the day post-inoculation
(dpi) at which animals were necropsied. Blue dots represent Llscore values (n = 227). The arrow indicates that Llscore
peaked when necropsies were performed at 28 dpi. The orange line and the blue shadow symbolize the predictions and
their range of the additive model (GAM) at 95% confidence interval, respectively.
https://doi.org/10.1371/journal.pone.0181194.g004
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evaluate the performance of experimental infections in pigs. Along the same line, Toma´s et al.
(2008) identified factors with a relevant influence on the expression of clinical postweaning
multisystemic wasting syndrome (PMWS) under experimental conditions, albeit different sta-
tistical techniques were applied [26]. Recursive partitioning is particularly well suited for
exploring complex relationships, where there is often little knowledge nor predictions regard-
ing which and how variables are related [17]. In the present work, recursive partitioning was
used to create a decision tree that defined an easy to visualize linear combination of continuous
and categorical explanatory variables (InAge, Asource, InRoute, Strain, InType, InDays, Dose,
CoIn and Nweek) to predict a continuous response variable (Llscore). Moreover, recursive
partitioning provides a better ability to handle missing values in both explanatory and
response variables than other regression techniques [18]. Missing data was perhaps one of the
most important limitations of the present systematic review, being common within experi-
mental units of different studies. For instance, the pig genetics could not be considered because
in most works the breed used was not specified.
In the first fitted regression tree containing all explanatory variables, the most determinant
factor associated to the presence of lung lesions in experimental trials was found to be the study
duration (Nweek). Henceforth, and to further examine such relationship, a complementary
Fig 5. Final regression tree resulting from experimental units with a maximum duration of 8 weeks post-inoculation. The numbers into the
circles represent the mean value of Llscore variable in “n” experimental units. Blue values aside the lines represent the different categories of the
corresponding variables.
https://doi.org/10.1371/journal.pone.0181194.g005
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analysis was performed by means of GAM. In this way, GAM analysis revealed that lung lesion
scores peaked when the Llscore was assessed at 4 wpi, being congruent with those studies
indicating that macroscopic lung lesions reach their maximum level around that moment [7,
8]. Hence, the present results support this lapse of time as the standard for the assessment of
lung scores. However, it is worth mentioning that the infection model of 4 wpi might not be
suitable for all types of experimental conditions [13, 27]. In fact, results indicated that the
time period that should not be exceeded to evaluate lung pathology is 8 wpi. Accordingly,
those experiments quantifying lung lesions over 8 wpi aimed principally to assess M. hyopneu-
moniae transmission and persistence instead of lung pathology [28–30].Taking into account
all the above, final tree models were applied to data from experimental units of less duration
than 8 wpi, and the most relevant factors to be accounted for inducing lung lesions suggestive
of MP appeared to be the M. hyopneumoniae strain (Strain) followed by the age of animals at
inoculation (InAge), co-infection with other swine pathogens (CoIn) and, finally, the source
of the animals (Asource).
Differences in virulence between M. hyopneumoniae strains have been described [9, 10].
Despite antigenic and genetic differences between isolates have been demonstrated [31, 32], it
is still not known whether such differences correlate with dissimilarities in virulence [10, 33,
34]. By recursive partitioning, the M. hyopneumoniae strains assessed were split into two
groups, one leading to higher lung lesion score outcomes than the other. Thus, the obtained
results support the already reported high virulence of some M. hyopneumoniae strains such as
Hillcrest [23] or even the lack of pathogenicity of J strain [35, 36], from which some current
M. hyopneumoniae commercial vaccines are based [37]. On the contrary, the American 232
and the Belgian F7, recognized as high virulent strains [9, 38], were found less appropriate for
severe MP reproduction than other M. hyopneumoniae strains. As a distinctive condition,
simultaneous or subsequent inoculations with more than one strain did not result in more
severe lung lesions. Although some studies have suggested an enhanced effect of multiple
infections with different M. hyopneumoniae strains [27, 34, 39], our analyses support findings
reported by Charlebois et al. (2014), in which no link was found between lungs harboring
more than one strain and lung lesion severity. Notwithstanding, given that data from single M.
hyopneumoniae strain inoculations predominate over data from multiple strain co-inocula-
tions, the obtained results should be corroborated. Additionally, differences between M. hyop-
neumoniae strains might be explained, among others, by the number of in vitro passages,
which has been discussed to result in pathogenicity differences [36]. Unfortunately, this factor
could not be addressed because it was not explicitly mentioned in an extensive number of
publications.
Immunopathological events are considered to play an imperative role in the pathogenesis
of M. hyopneumoniae infection [1, 40]. Consequently, the higher potential of success obtained
for inoculations in pigs older than 3.5 weeks of age could be explained by the fact that some
mechanisms from both the innate and acquired immunity are less developed at birth and
mature with age [1]. Indeed, under conditions of a previous study [41], no differences were
detected in susceptibility of pigs to M. hyopneumoniae between 3 and 12 weeks of age. Further-
more, in almost all the analyzed studies, inoculated pigs were tested to be seronegative against
M. hyopneumoniae, excluding conferred protection of younger pigs by passively acquired
maternal antibodies. While M. hyopneumoniae is considered a primary respiratory pathogen,
thus, able to induce disease by itself, the use of co-infections have been also proven effective to
induce M. hyopneumoniae-like lung lesions in several experiments. However, whether co-
infection with other swine pathogens influences the severity of M. hyopneumoniae infection
(macroscopic lung lesions) is still under debate. Whereas some studies found no potentiation
of pneumonia by other microorganisms [4, 6, 25, 42], others demonstrated that pneumonia in
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co-inoculated pigs was more severe than in pigs inoculated only with M. hyopneumoniae [5,
43, 44]. Despite such discrepancies, results of the recursive partitioning analysis indicate that
co-infection models might have the potential for reproducing pneumonia than the inoculation
of M. hyopneumoniae alone. Regrettably, the lack of more experimental units using co-infec-
tion models hindered the evaluation of the co-inoculated pathogens separately, being all of
them pooled and evaluated together. The latter might be taken into account since the lung
lesion outcome may vary depending on the co-inoculated microorganism. Lastly, the use of
SPF pigs resulted to be an important feature to effectively reproduce MP. Unfortunately, crite-
ria applied to define SPF pigs by the authors reporting their use were unknown, becoming dif-
ficult to precisely explain the importance of such factor on lung lesion outcome. Nevertheless,
and independently of the source, pigs used in M. hyopneumoniae experimental models were,
in general terms, M. hyopneumoniae-free by means of serology and/or polymerase chain reac-
tion (PCR) techniques. Hence, pigs naive to M. hyopneumoniae are probably required to
increase the chance to achieve severe MP.
All the other evaluated variables (InRoute, InDays, InType and Dose) were found not rele-
vant to explain MP variability. Contrarily, higher percentage of animals affected by MP as well
as mean lung lesion score have been reported in pigs inoculated endotracheally in comparison
with pigs inoculated intranasally or by aerosolization [13]. Inoculation with lung homogenate
(LH) taken from infected pigs might has the potential to introduce adventitious agents as well
as aggravate the inflammatory response due to the administration of foreign antigens [11].
However and in accordance to the obtained results, no significant differences were observed
among animals inoculated with LH and CT prepared from the same lung homogenate in
terms of lung lesions achieved [45]. Furthermore, an inoculum dose-dependent response has
been reported in M. hyopneumoniae challenge studies, in which very high doses are necessary
to achieve clinical disease [12]. In agreement, descriptive statistics revealed an overall high
dose (CCU) used per pig.
Importantly, care must be taken in drawing conclusions from the obtained results. The sta-
tistical approach performed in the present study was probably hampered by the broad differ-
ences in the applied conditions between experimental units, which make it difficult to assess
the effect of a particular condition in the lung lesion outcome. Moreover, inherent limitations
of the included publications and the systematic review process must be also taken into account.
In this respect, the trend towards publishing only positive results (e.g. experiments in which
MP was successfully achieved) and the exclusion of those studies that did not fulfil all the sys-
tematic review inclusion criteria (e.g. experiments in which MP was induced but no informa-
tion in regards of lung lesion score was provided), probably lead to biases that could have
influenced the obtained results. Another important reason for bias is linked to the high preva-
lence of some particular conditions within a variable, such as the lung lesion assessment at 4
wpi as striking example. Thus, the importance of such widely extended conditions within M.
hyopneumoniae experimental inoculation protocols could be overestimated in the statistical
analysis.
Conclusion
The present study broadens the current understanding in regards to M. hyopneumoniae exper-
imental swine models and constitutes the first insight into conditions needed to induce lung
lesions suggestive of MP under experimental settings. Thus, obtained results might serve as a
basis for debate in the search for a M. hyopneumoniae experimental model seeking to induce
severe MP. While the M. hyopneumoniae strain used may depend basically on the strain avail-
ability, other easily modifiable conditions might be taken into account in experimental models.
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Therefore, the highest likelihood to achieve severe MP would require lung lesion assessment
within a period below 8wpi and include inoculation of SPF (M. hyopneumoniae free) pigs
older than3.5 weeks of age and, preferably, in co-infection with another swine respiratory
pathogen as a triggering factor.
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